Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boersma J. W. Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone. Scand J Rheumatol. 1976;5(1):60–64. [PubMed] [Google Scholar]
- Hart F. D., Huskisson E. C. Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use. Drugs. 1984 Mar;27(3):232–255. doi: 10.2165/00003495-198427030-00004. [DOI] [PubMed] [Google Scholar]
- Inman W. H. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Br Med J. 1977 Jun 11;1(6075):1500–1505. doi: 10.1136/bmj.1.6075.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kraag G. R. Rare toxicity with nonsteroidal antiinflammatory drugs. J Rheumatol. 1985 Feb;12(1):1–3. [PubMed] [Google Scholar]
- Lussier A., de Medicis R. Correlation between ossification and inflammation using a rat experimental model. J Rheumatol Suppl. 1983 Dec;11:114–117. [PubMed] [Google Scholar]
- O'Brien W. M., Bagby G. F. Rare adverse reactions to nonsteroidal antiinflammatory drugs. J Rheumatol. 1985 Feb;12(1):13–20. [PubMed] [Google Scholar]
- Venning G. R. Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide? Br Med J (Clin Res Ed) 1983 Jan 15;286(6360):199–202. doi: 10.1136/bmj.286.6360.199. [DOI] [PMC free article] [PubMed] [Google Scholar]